Description
COVIDH TECHNOLOGIES LIMITED has fixed October 24, 2025 as the record date for rights issue offering 25 equity shares for every 1 share held at par value of Rs. 10 each.
Summary
COVIDH TECHNOLOGIES LIMITED (BSE Code: 534920) has announced a rights issue with a record date of October 24, 2025. The company is offering 25 equity shares of Rs. 10 each at par for every 1 existing equity share held. Trading in the company’s shares will be conducted on an ex-rights basis from October 24, 2025 (Settlement No. DR-742/2025-2026).
Key Points
- Company: COVIDH TECHNOLOGIES LIMITED (BSE Code: 534920)
- Rights ratio: 25 equity shares for every 1 existing share held
- Issue price: Rs. 10 per share (at par)
- Record date: October 24, 2025
- Ex-rights date: October 24, 2025
- Settlement number: DR-742/2025-2026
- Security type: Dematerialised securities in rolling settlement segment
Regulatory Changes
No regulatory changes announced. This is a standard corporate action notification.
Compliance Requirements
- Trading members must execute all transactions in COVIDH TECHNOLOGIES LIMITED shares on an ex-rights basis from October 24, 2025
- Shareholders on record as of October 24, 2025 will be eligible to participate in the rights issue
- Trading members are required to take note of the ex-rights trading arrangement
Important Dates
- October 17, 2025: Circular issued
- October 24, 2025: Record date for rights issue eligibility
- October 24, 2025: Ex-rights trading commences (Settlement No. DR-742/2025-2026)
Impact Assessment
Shareholder Impact: Extremely high dilution potential with a 25:1 rights ratio. Existing shareholders who do not participate in the rights issue will face significant dilution of their ownership stake (approximately 96% dilution if they don’t subscribe).
Market Impact: The ex-rights trading will result in price adjustment to reflect the rights entitlement. The theoretical ex-rights price will be significantly lower than the cum-rights price given the substantial dilution factor.
Liquidity Impact: The large number of new shares (25x the existing base) will substantially increase the company’s equity base and may impact trading patterns and liquidity post-issue.
Financial Impact: The company is raising capital at par value, suggesting potential fundraising for expansion, debt reduction, or working capital requirements. The at-par pricing indicates no premium, which may reflect the company’s current market position or strategic pricing for maximum participation.
Impact Justification
Significant corporate action with 25:1 rights ratio, materially dilutive for existing shareholders who don't participate. High impact for COVIDH shareholders but limited market-wide significance.